G6PD and metastatic malignant neoplasm in the lymph nodes: Glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme of the PPP, is overexpressed in OSCC and correlates with advanced disease, lymph node metastasis, and poor prognosis [60].